All In MedTech

Device Trial Radar · NCT05142566

MANTA Ultrasound Closure Study

Prospective Multicenter MANTA™ Vascular Closure Device Ultrasound Guided Closure Study

Last checked: Nov 20, 2026Latest source record: Jul 27, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

17

Actual

Start

Aug 9, 2022

Primary completion

Jan 11, 2023

Study completion Jan 11, 2023

Sponsor

Lead sponsor
Essential Medical, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Teleflex
First posted
Dec 2, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Demonstrate the safety of MANTA Vascular Closure Device (VCD) ultrasound (U/S) guided closure in patients undergoing elective TAVR procedures with planned percutaneous femoral arterial access.

Conditions

  • Femoral Arteriotomy Closure

Interventions

  • MANTA Vascular Closure DeviceDevice

    Evaluate the safety of ultrasound guided deployment of MANTA VCD.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of Any Large Bore Access-site Related VARC-2 Major Vascular ComplicationTime frame: within 30 days

Locations

6 sites in 2 countries. Site status is shown where the registry gives one.

  • Washington Hospital Center

    Washington D.C., District of Columbia

  • Henry Ford

    Detroit, Michigan

  • University of Buffalo

    Buffalo, New York

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.